IndiaNivesh maintains ‘accumulate’ rating on IPCA Labs, target price Rs 1,550
IndiaNivesh projects a 17% sales CAGR and 29% PAT CAGR over FY19–22, wherein the EBITDA margin is expected to expand by 200bps to 22% by FY22.from Markets-Economic Times https://ift.tt/38r06c3
Post a Comment